Literature DB >> 7892417

Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.

S Ferré1, R Schwarcz, X M Li, P Snaprud, S O Ogren, K Fuxe.   

Abstract

Stimulation of adenosine A2 receptors (with the selective adenosine A2 agonist CGS 21680) in rat striatal membrane preparations, produces a decrease in both the affinity of D2 receptors and the transduction of the signal from the D2 receptor to the G protein. This intramembrane A2-D2 interaction might be responsible for the behavioural depressant effects of adenosine agonists and for the behavioural stimulant effects of adenosine antagonists such as caffeine and theophylline. Dopamine denervation induces an increase in the intramembrane A2-D2 interaction, which may underlie the observed higher sensitivity to the behavioural effects induced by adenosine antagonists found in these animals. The present study was designed to examine if chronic treatment with haloperidol, which also produces dopamine receptor supersensitivity, is also associated with an increase in the intramembrane A2-D2 interaction in the neostriatum and with a higher sensitivity to the behavioural effects induced by adenosine antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892417     DOI: 10.1007/bf02245329

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Stimulation of adenosine A2 receptors induces catalepsy.

Authors:  S Ferré; A Rubio; K Fuxe
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

2.  Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680.

Authors:  M F Jarvis; M Williams
Journal:  Eur J Pharmacol       Date:  1989-09-13       Impact factor: 4.432

3.  Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor.

Authors:  F Libert; E Passage; M Parmentier; M J Simons; G Vassart; M G Mattei
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

Review 4.  Modulation of neurotransmission by purine nucleotides and nucleosides.

Authors:  B B Fredholm; P Hedqvist
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

5.  Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.

Authors:  K Fuxe; U Ungerstedt
Journal:  Med Biol       Date:  1974-02

6.  Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

Authors:  I Creese; S H Snyder
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

7.  Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.

Authors:  K A Neve; C A Altar; C A Wong; J F Marshall
Journal:  Brain Res       Date:  1984-06-04       Impact factor: 3.252

8.  Molecular cloning and expression of an adenosine A2b receptor from human brain.

Authors:  K D Pierce; T J Furlong; L A Selbie; J Shine
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

9.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.

Authors:  S Ferré; M Herrera-Marschitz; M Grabowska-Andén; M Casas; U Ungerstedt; N E Andén
Journal:  Eur J Pharmacol       Date:  1991-01-03       Impact factor: 4.432

View more
  4 in total

1.  Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia.

Authors:  C-J Hong; H-C Liu; T-Y Liu; D-L Liao; S-J Tsai
Journal:  J Neural Transm (Vienna)       Date:  2005-02-22       Impact factor: 3.575

Review 2.  Implication of the purinergic system in alcohol use disorders.

Authors:  Liana Asatryan; Hyung W Nam; Moonnoh R Lee; Mahesh M Thakkar; M Saeed Dar; Daryl L Davies; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

3.  Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.

Authors:  S Aoyama; H Kase; E Borrelli
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

4.  Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia.

Authors:  Marta Valle-León; Luis F Callado; Ester Aso; María M Cajiao-Manrique; Kristoffer Sahlholm; Marc López-Cano; Concepció Soler; Xavier Altafaj; Masahiko Watanabe; Sergi Ferré; Víctor Fernández-Dueñas; José M Menchón; Francisco Ciruela
Journal:  Neuropsychopharmacology       Date:  2020-10-03       Impact factor: 7.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.